Sunday, November 29, 2020

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore The volunteer is falsely laying the blame for his medical problems on the trial of COVID-19 vaccine Covishield, said Serum Institute of India

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-vaccine-|-sii-rejects-claimscovishield39s-adverse-effect-threatens-to-seek-damagesexcessrs-100-crore_14538241.html

No comments:

Post a Comment

India a key beneficiary of global portfolio diversification: Jonathan Schiessl

Global equities are performing well despite concerns about tariffs and geopolitical issues. Investors are seemingly ignoring negative news, ...